Concepedia

Publication | Open Access

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia

33

Citations

21

References

2019

Year

References

YearCitations

Page 1